Batch variability of bacitracin: HPLC versus MEKC

Area of Science:

• Analytical Chemistry
• Pharmacology

Background:

• Bacitracin is a crucial antibiotic peptide complex.
• Ensuring bacitracin quality and composition is vital for pharmaceutical applications.
• Regulatory standards, such as the European Pharmacopoeia, dictate quality control measures.

Purpose of the Study:

• To analyze and compare the composition of ten bacitracin lots from the European market.
• To evaluate the effectiveness of High-Performance Liquid Chromatography (HPLC) versus micellar electrokinetic chromatography (MEKC) for bacitracin analysis.

Main Methods:

• Analysis of ten bacitracin lots using the European Pharmacopoeia HPLC method.
• Orthogonal analysis employing micellar electrokinetic chromatography (MEKC).
• Quantification of key bacitracin components, including bacitracin A, B1, and B3.

Main Results:

• HPLC analysis did not achieve baseline separation of all bacitracin components.
• MEKC demonstrated significantly higher selectivity, enabling complete separation of bacitracin congeners.
• Bacitracin lots were classifiable into two main groups based on bacitracin A, B1, and B3 content, with one lot being an outlier.
• All analyzed lots complied with European Pharmacopoeia requirements.

Conclusions:

• MEKC provides superior resolution for complex peptide mixtures like bacitracin compared to standard HPLC.
• Despite compositional variations, all studied bacitracin lots met established quality standards.
• The findings support the utility of MEKC as a complementary or alternative method for robust bacitracin quality control.